TCON (TRACON Pharmaceuticals Inc.) Gross Margin

Corporate emblem and logo of TRACON Pharmaceuticals, Inc (TCON)

TRACON Pharmaceuticals specializes in developing targeted antibodies, where success depends on patent disputes. The gross margin structure reflects a decline in quotes, with the value 0.00 representing the current metric. Despite attempts to build a tumor-fighting pipeline, TRACON Pharmaceuticals is liquidating assets following the closure of key studies and the winding down of all operating activities.

TRACON (TCON): Gross Margin from 07/04/2022 to 08/04/2024

Comprehensive metric breakdowns and analytics for TRACON (TCON)

Manufactured product of TRACON Pharmaceuticals Inc.

Investors are assessing fundamental capital risks through the lens of direct cost management efficiency. Amidst a staffing collapse and the loss of research potential at TRACON Pharmaceuticals (TCON), the business's gross margin becomes a critical indicator of survival. This metric measures the portion of revenue minus the cost of goods sold, determining whether the reduced administrative core can maintain operating profitability without external support.

Direct competitors

Return on Gross Profit Tempus AI Inc|QGEN (Qiagen NV) - Gross Margin|Return on Gross Profit Ionis Pharma (IONS)|Gross Profitability Repligen Corp (RGEN)|RNA - Gross Profit Margin|crisprtx.com - Return on Gross Profit|Gross Profit Rate WGS|RARE - Gross Profitability|Beam Tx (BEAM) - Return on Gross Profit|SRPT (Sarepta Therapeutics Inc) - Return on Gross Profit|TWST: Gross Profit Ratio|TXG (10xgenomics.com) - Gross Margin|NTLA (Intellia Therapeutics, Inc.) - Gross Profit Ratio|Gross Profitability Stoke Corp (STOK)|Return on Sales by Gross Profit BioLife|Gross Margin WVE (Wave Life Sciences Ltd)|MAZE: Gross Return on Sales|Sionna Therapeutics, Inc. - Gross Margin|Gross Profit Rate PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Return on Gross Profit|QURE - Return on Sales by Gross Profit|MGTX (MeiraGTx Corp) - Gross Margin|Gross Profit Margin REGENXBIO Inc. RGNX|Gross Profitability Solid Biosciences (SLDB)|Ocugen Corp - Gross Return on Sales|Gross Profitability Pacific Biosciences PACB|Gross Profit Ratio BNTC (Benitec)|Design Corp - Gross Margin|Rocket Pharmaceuticals - Gross Profit Ratio|Gross Return on Sales 4D Molecular Therapeutics, Inc.|Gross Profit Margin Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Gross Margin|Gross Profit Margin Editas EDIT|Gross Margin SLN|ProQR Therapeutics - Gross Return on Sales|Gross Margin CDXS (Codexis, Inc.)|SGMO: Gross Return on Sales|Nautilus Biotechnology - Gross Margin|Gross Profit Rate MGX (Metagenomi, Inc)|DTIL: Gross Margin|GBIO: Gross Profit Ratio|Gross Profitability Boundless Bio Inc.|Return on Gross Profit Exicure (XCUR)|Gross Margin IMNN|PHIO (Phio Pharmaceuticals Corp.) - Gross Profit Rate|Mustang Bio, Inc. - Return on Gross Profit|RNAZ - Return on Gross Profit|BNGO: Return on Gross Profit|APDN (Applied DNA Sciences Inc) - Gross Return on Sales|BLUE (Bluebird Bio) - Return on Gross Profit|ImmunoPrecise Antibodies Ltd - Gross Profit Rate|OMGA (Omega Therapeutics Inc) - Gross Margin|Gross Profitability OMIC|Gross Profitability Regulus Therapeutics Inc. (RGLS)|Return on Gross Profit Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Return on Gross Profit|Unity Biotechnology, Inc - Gross Profitability